Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer letters

Showing results (91-100 of 17,050) with videos related to

Pageof 1,705
Sort By:
Cancer Letters|August 6, 2010
Antagonists of IAP proteins as cancer therapeuticsJasmin N Dynek, Domagoj Vucic
Cancer Letters|August 6, 2010
Targeting apoptosis pathways in cancer by Chinese medicineMin Li-Weber
Cancer Letters|August 10, 2010
Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphomaSung Soo Kim, Victoria E Ruiz, Jaqueline D Carroll, et al.
Cancer Letters|June 24, 2010
Leukemia inhibitory factor can mediate Ras/Raf/MEK/ERK-induced growth inhibitory signaling in medullary thyroid cancer cellsDumrongkiet Arthan, Seung-Keun Hong, Jong-In Park
Cancer Letters|August 17, 2010
Vasoactive intestinal peptide (VIP) induces malignant transformation of the human prostate epithelial cell line RWPE-1Ana B Fernández-Martínez, Ana M Bajo, M Isabel Arenas, et al.
Cancer Letters|August 25, 2010
Targeting ER stress induced apoptosis and inflammation in cancerTom Verfaillie, Abhishek D Garg, Patrizia Agostinis
Cancer Letters|February 12, 2011
UCH-L1 promotes cancer metastasis in prostate cancer cells through EMT inductionMin Jung Jang, Sung Hee Baek, Jung Hwa Kim
Cancer Letters|February 15, 2011
Targeting apoptosis pathways in cancer stem cellsMichele Signore, Lucia Ricci-Vitiani, Ruggero De Maria
Cancer Letters|February 15, 2011
Inhibition of topoisomerase IIα: novel function of wedelolactonePetr Benes, Lucia Knopfova, Filip Trcka, et al.
Cancer Letters|February 15, 2011
Molecular competition between plasminogen activator inhibitors type -1 and -2 for urokinase: Implications for cellular proteolysis and adhesion in cancerSergei Lobov, Marie Ranson
Pageof 1,705

Showing results (91-100 of 17,050) with videos related to

Sort By:
Pageof 1,705
Cancer Letters|August 6, 2010
Antagonists of IAP proteins as cancer therapeuticsJasmin N Dynek, Domagoj Vucic
Cancer Letters|August 6, 2010
Targeting apoptosis pathways in cancer by Chinese medicineMin Li-Weber
Cancer Letters|August 10, 2010
Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphomaSung Soo Kim, Victoria E Ruiz, Jaqueline D Carroll, et al.
Cancer Letters|June 24, 2010
Leukemia inhibitory factor can mediate Ras/Raf/MEK/ERK-induced growth inhibitory signaling in medullary thyroid cancer cellsDumrongkiet Arthan, Seung-Keun Hong, Jong-In Park
Cancer Letters|August 17, 2010
Vasoactive intestinal peptide (VIP) induces malignant transformation of the human prostate epithelial cell line RWPE-1Ana B Fernández-Martínez, Ana M Bajo, M Isabel Arenas, et al.
Cancer Letters|August 25, 2010
Targeting ER stress induced apoptosis and inflammation in cancerTom Verfaillie, Abhishek D Garg, Patrizia Agostinis
Cancer Letters|February 12, 2011
UCH-L1 promotes cancer metastasis in prostate cancer cells through EMT inductionMin Jung Jang, Sung Hee Baek, Jung Hwa Kim
Cancer Letters|February 15, 2011
Targeting apoptosis pathways in cancer stem cellsMichele Signore, Lucia Ricci-Vitiani, Ruggero De Maria
Cancer Letters|February 15, 2011
Inhibition of topoisomerase IIα: novel function of wedelolactonePetr Benes, Lucia Knopfova, Filip Trcka, et al.
Cancer Letters|February 15, 2011
Molecular competition between plasminogen activator inhibitors type -1 and -2 for urokinase: Implications for cellular proteolysis and adhesion in cancerSergei Lobov, Marie Ranson
Pageof 1,705